Technical Analysis for VRCA - Verrica Pharmaceuticals Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Down |
Historical VRCA trend table... |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Fell Below 20 DMA | Bearish | 0.00% | |
Crossed Above 20 DMA | Bullish | -11.83% | |
Pocket Pivot | Bullish Swing Setup | -11.83% | |
Fell Below 20 DMA | Bearish | -6.45% | |
Crossed Above 20 DMA | Bullish | -6.84% | |
Narrow Range Bar | Range Contraction | -6.84% | |
NR7 | Range Contraction | -6.84% | |
Fell Below 20 DMA | Bearish | -2.70% | |
Wide Bands | Range Expansion | -6.06% | |
Wide Bands | Range Expansion | -12.01% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time | |
---|---|---|
Fell Below Lower Bollinger Band | about 6 hours ago | |
60 Minute Opening Range Breakdown | about 6 hours ago | |
Down 10% | about 6 hours ago | |
3x Volume Pace | about 9 hours ago | |
Fell Below Previous Day's Low | about 9 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 09/27/2019
Verrica is a pharmaceutical company focused on identifying, developing and commercializing innovative pharmaceutical products for the treatment of skin diseases with significant unmet needs. The company’s lead product candidate, VP-102, is currently being evaluated in two Phase 3 clinical trials for the treatment of molluscum and in a Phase 2 clinical trial for the treatment of common warts.
Sector: Healthcare
Industry: Biotechnology
Keywords: Pharmaceutical Pharmaceutical Industry Pharmaceutical Products Medication Clinical Trial Skin Diseases Common Warts Treatment Of Skin Diseases
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Pharmaceutical Pharmaceutical Industry Pharmaceutical Products Medication Clinical Trial Skin Diseases Common Warts Treatment Of Skin Diseases
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 16.61 |
52 Week Low | 6.02 |
Average Volume | 81,410 |
200-Day Moving Average | 10.19 |
50-Day Moving Average | 12.92 |
20-Day Moving Average | 14.48 |
10-Day Moving Average | 14.38 |
Average True Range | 1.21 |
ADX | 32.1 |
+DI | 26.24 |
-DI | 19.29 |
Chandelier Exit (Long, 3 ATRs ) | 12.99 |
Chandelier Exit (Short, 3 ATRs ) | 15.54 |
Upper Bollinger Band | 15.86 |
Lower Bollinger Band | 13.09 |
Percent B (%b) | 0.09 |
BandWidth | 19.15 |
MACD Line | 0.40 |
MACD Signal Line | 0.58 |
MACD Histogram | -0.1855 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 15.77 | ||||
Resistance 3 (R3) | 15.98 | 15.37 | 15.37 | ||
Resistance 2 (R2) | 15.37 | 14.75 | 15.27 | 15.23 | |
Resistance 1 (R1) | 14.36 | 14.37 | 14.06 | 14.15 | 15.09 |
Pivot Point | 13.75 | 13.75 | 13.60 | 13.65 | 13.75 |
Support 1 (S1) | 12.74 | 13.13 | 12.44 | 12.53 | 11.59 |
Support 2 (S2) | 12.13 | 12.75 | 12.03 | 11.45 | |
Support 3 (S3) | 11.12 | 12.13 | 11.32 | ||
Support 4 (S4) | 10.91 |